Phase 1 Trial of Ebola Vaccine in Mali

NCT02267109 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Ebola Virus Disease
Hemorrhagic Fever

Interventions

BIOLOGICAL: Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z
BIOLOGICAL: Booster-MVA-BN® Filo or saline placebo

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]
[object Object]
[object Object]